Weekly low-dose doxorubicin in advanced breast cancer
Specenier, P.; Thomas, J.
Cancer Treatment Reports 70(6): 815
1986
ISSN/ISBN: 0361-5960 PMID: 3731142 Document Number: 284742
Document emailed within 1 workday
Related Documents
Jönsson, P.E.; Malmberg, M.; Ericsson, M.; Ryden, S. 1991: Weekly dose adriamycin as first line chemotherapy in advanced breast cancer Anticancer Research 11(2): 877-879Köhne, C.H.; Daniel, P.T.; Dörken, B. 1997: The value of weekly high dose infusional 5-fluorouracil in the treatment of advanced colorectal cancer Tumori 83(1 Suppl): S56-S60
Martoni, A.; Cricca, A.; Guaraldi, M.; Covizzi, M.; Farris, A.; Pannuti, F. 1992: Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer Anticancer Research 12(3): 607-612
Barni, S.; Archili, C.; Lissoni, P.; Paolorossi, F.; Crispino, S.; Tancini, G. 1993: A weekly schedule of epirubicin in pretreated advanced breast cancer Tumori 79(1): 45-48
Lorvidhaya, V.; Kamnerdsupaphon, P.; Chitapanarux, I.; Srisukho, S.; Trakultivakorn, H.; Sumitsawan, S.; Sukthomya, V.; Tonusin, A. 2003: Combination of vinorelbine + doxorubicin in advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(8): 1131-1138
Wada, Y.; Otoshi, M.; Jitsuko, A.; Nishikawa, H.; Takahara, S.; Tsubono, M.; Imai, S. 2007: A phase Ii study of weekly paclitaxel for advanced or recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(7): 1041-1045
Kimijima, I.; Watanabe, T.; Sagara, H.; Ohtake, T.; Tsuchiya, A.; Abe, R. 1999: Low-dose weekly administration of docetaxel for metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 995-999
Christodoulou, C.; Klouvas, G.; Pateli, A.; Mellou, S.; Sgouros, J.; Skarlos, D.V. 2003: Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer Anticancer Research 23(1b): 737-744
Okubo, A.; Hino, N.; Ikushima, Y.; Mori, R.; Amano, S.; Tsuyuguchi, M.; Sounaka, Y.; Wada, D.; Yamasaki, S.; Miyake, H.; Miyoshi, T.; Ikawa, K.; Ogata, Y.; Matsuoka, H.; Kawakita, N.; Mikami, C. 2010: Two elderly patients with advanced breast cancer successfully treated by tri-weekly docetaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 911-914
Amadori, D.; Frassineti, G.L.; Zoli, W.; Tienghi, A.; Ravaioli, A.; Casadei Giunchi, D.; Gentile, A.; Salzano, E. 1996: A Phase I/Ii study of paclitaxel and doxorubicin in the treatment of advanced breast cancer Seminars in Oncology 23(1 Suppl 1: 19-23
Kimura, M.; Koida, T.; Yanagita, Y. 2000: Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(11): 1703-1708
Sledge, G.W.; Robert, N.; Sparano, J.A.; Cogleigh, M.; Goldstein, L.J.; Neuberg, D.; Rowinsky, E.; Baughman, C.; McCaskill-Stevens, W. 1995: Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer Seminars in Oncology 22(3 Suppl 6: 105-108
Dank, M.; Zergenyi, E.; Domotori, Z.S.; Lahm, E.; Kulka, J. 2003: Primary systemic therapy (PST) of locally advanced breast cancer using Doxorubicin/Docetaxel combination Anticancer Research 23(3c): 2879-2880
Katsumata, K.; Yamamoto, K.; Ashizawa, T.; Sumi, T.; Murohashi, T.; Katayanagi, S.; Kusama, M.; Koyanagi, Y. 2001: Recurrent breast cancer successfully treated with a weekly dose of paclitaxel--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(1): 75-78
Sparano, J.A. 1998: Compilation of phase i and Ii trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies Seminars in Oncology 25(6 Suppl 13: 10-15
Yayoi, E.; Furukawa, J.; Takatsuka, Y.; Kobayashi, T.; Aikawa, T.; Maeura, Y.; Kaji, M.; Kotsuma, Y. 1992: Intra-arterial infusion chemotherapy in the treatment of advanced breast cancer--doxorubicin versus epirubicin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1621-1624
Sledge, G.W.; Robert, N.; Sparano, J.A.; Cobeligh, M.; Goldstein, L.J.; Neuberg, D.; Rowinsky, E.; Baughman, C.; McCaskill-Stevens, W. 1994: Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience Seminars in Oncology 21(5 Suppl 8: 15-18
Seidman, A.D.; Hudis, C.A.; McCaffrey, J.; Tong, W.; Currie, V.; Moynahan, M.E.; Theodoulou, M.; Tepler, I.; Gollub, M.; Norton, L. 1997: Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer Seminars in Oncology 24(5 Suppl 17: S17
Burtness, B.; Windsor, S.; Holston, B.; DiStasio, S.; Staugaard-Hahn, C.; Abrantes, J.; Kneuper-Hall, R.; Farber, L.; Orell, J.; Bober-Sorcinelli, K.; Haffty, B.G.; Reiss, M. 1999: Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting Cancer Journal From Scientific American 5(4): 224-229
Kimura, M.; Sano, M.; Tabei, T.; Asaga, T.; Ando, J.; Fujii, H.; Yamamoto, N.; Kurosumi, M. 2005: Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 335-339